HTT and Huntington disease: The use of an adaptor that contains two copies of polyQ binding sequences and two different KFERQ motifs, directs specifically mutant HTT to the CMA machinery for its degradation, ameliorating symptoms, and extending the life span of an HD mouse model (Bauer et al., 2010).